Viewing Study NCT03821792


Ignite Creation Date: 2025-12-24 @ 3:24 PM
Ignite Modification Date: 2026-01-06 @ 1:55 PM
Study NCT ID: NCT03821792
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-10
First Post: 2019-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module